ورود
مقالات فارسیISIکنفرانسهاژورنالها

Inhibition of breast cancer metastasis by co-transfection of miR-۳۱/۱۹۳b-mimics

محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 21، شماره: 4
سال انتشار: 1397
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 163

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:
https://civilica.com/doc/1295329

شناسه ملی سند علمی:

JR_IJBMS-21-4_014

تاریخ نمایه سازی: 27 مهر 1400

چکیده مقاله:

Objective(s): Various studies have been conducted to reduce the metastatic behavior of cancerous cells. In this regard, ectopic expression of anti-metastatic microRNAs by miR-mimic and miR-restoration-based therapies could bring new insights to the field. In the present study, the consequences of co-transfecting breast cancer cell lines with miR-۱۹۳b and miR-۳۱ were investigated via invasion and migration assays.Materials and Methods: Double stranded oligonucleotide of mature miR-۱۹۳b-۳p and miR-۳۱-۵p were cloned into pcDNA ۶.۲gw/EmGFP plasmid. The resulting plasmids were used for transfection. Real time-PCR was performed to assess the expression of miR-۱۹۳b and miR-۳۱ as well as Ras homolog gene family member A (RhoA) and urokinase-type plasminogen activator (uPA) as miR targets. Scratch, Transwell migration and Matrigel invasion assays were carried out to assess the extent of migration and invasion of cell lines.Results: The most significant increase in expression of miRs belonged to the single transfection of mimic-miRs in MDA-MB۲۳۱. Although the co-transfection was not as successful as single transfection in miR expression, it was significantly more effective in inhibition of the cells invasive potential. Conclusion: Although the miR-restoration therapy based on co-transfection of two miRs could be less effective in expression of each miRNA, the resulting decrease in metastatic behavior of the cells is more significant due to collective effect of co-transfection to decrease target gene expression. Our results revealed that employing this sort of combinatorial strategies could lead to more efficient reduction in metastatic behavior. It seems that using this strategy would bring about more successful therapeutic outcomes.

کلیدواژه ها:

Breast Cancer ، Metastasis ، miR-۳۱ ، miR-۱۹۳b ، RhoA ، uPA

نویسندگان

Zahra Sadat Hashemi

Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

mehdi Forouzandeh Moghadam

Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

Samila Farokhimanesh

Department of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran

masuomeh rajabibazl

Department of Clinical Biochemistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Esmaeil sadroddiny

Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, ۲۰۱۶. CA ...
  • Eccles SA, Welch DR. Metastasis: recent discoveries and novel treatment ...
  • Hashemi ZS, Forouzandeh Moghadam M, Soleimani M. Comparison of TGFbR۲ ...
  • Choghaei E, Khamisipour G, Falahati M, Naeimi B, Mossahebi-Mohammadi M, ...
  • Farokhimanesh S, Forouzandeh Moghadam M, Ebrahimi M, Ghamnak A, Hashemi ...
  • Farokhimanesh S, Forouzandeh Moghadam M, Ebrahimi M, Hashemi ZS, Ghamnak ...
  • Hashemi ZS, Khalili S, Forouzandeh Moghadam M, Sadroddiny E. Lung ...
  • Kouhkan F, Mohamadi Mosahebi M, Mohamadi S, Khamisipour G, Soufizomorrod ...
  • Langroudi L, Forouzandeh M, Soleimani M, Atashi A, Golestaneh AF. ...
  • Mohammadpour H, Khalili S, Hashemi ZS. Kremen is beyond a ...
  • Hashemi ZS, Forouzandeh Moghadam M, Soleimani M, Hafizi M, Amirizadeh ...
  • Khalili S, Rasaee M, Bamdad T. ۳D structure of DKK۱ ...
  • Hashemi ZS, Forouzandeh Moghadam M, Soleimani M. Comparison of the ...
  • Garofalo M, Croce CM. microRNAs: Master regulators as potential therapeutics ...
  • Nassar FJ, Nasr R, Talhouk R. MicroRNAs as biomarkers for ...
  • Banaei-Esfahani A, Moazzeni H, Nosar PN, Amin S, Arefian E, ...
  • Hurst DR, Edmonds MD, Welch DR. Metastamir: the field of ...
  • Felekkis K, Touvana E, Stefanou C, Deltas C. microRNAs: a ...
  • Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, ...
  • Ng EK, Li R, Shin VY, Jin HC, Leung CP, ...
  • Lu Z, Ye Y, Jiao D, Qiao J, Cui S, ...
  • Valastyan S, Weinberg RA. miR-۳۱: a crucial overseer of tumor ...
  • Valastyan S, Weinberg RA. Roles for microRNAs in the regulation ...
  • Chen J, Feilotter HE, Paré GC, Zhang X, Pemberton JG, ...
  • Hu H, Li S, Liu J, Ni B. MicroRNA-۱۹۳b modulates ...
  • Zhong Q, Wang T, Lu P, Zhang R, Zou J, ...
  • Li X, Yan P, Shao Z. Downregulation of miR-۱۹۳b contributes ...
  • Leivonen S, Mäkelä R, Östling P, Kohonen P, Haapa-Paananen S, ...
  • Gruppen F. MicroRNAs in breast cancer ۲۰۱۱ ...
  • Tang F, Zhang R, He Y, Zou M, Guo L, ...
  • Rasheed SAK, Teo CR, Beillard EJ, Voorhoeve PM, Zhou W, ...
  • Körner C, Keklikoglou I, Bender C, Wörner A, Münstermann E, ...
  • Long J, Ji Z, Jiang K, Wang Z, Meng G. ...
  • Hashemi ZS, Forouzandeh Moghadam M, Soleimani M. Comparison of TGFbR۲ ...
  • Surks HK, Richards CT, Mendelsohn ME. Myosin Phosphatase-Rho Interacting Protein. ...
  • Tang L, Han X. The urokinase plasminogen activator system in ...
  • Nanbu R, Menoud P-A, Nagamine Y. Multiple instability-regulating sites in ...
    • نمایش کامل مراجع